Search
Displaying results 671 to 676 of 676.
Biosafety Level 3 Laboratory
Biological agents of risk group 3 (RG3) pose a constant global as well as national challenge because they cause severe illnesses in humans against which there are usually no effective preventive or treatment measures. Since these pathogens can only be handled in special biosafety level 3 (BSL3) laboratories, the modern BSL3 laboratories at the HZI provide a technology platform that is indispensable in today's infection research - only in this way can our scientists develop new therapies, prevention measures or diagnostic procedures against these pathogens.
Microbial Interactions and Processes
Microorganisms in the environment are living in complex and interacting communities. Also the surfaces of the human body are inhabited by microorganisms, where the bacterial cell number significantly exceeds that of the human cells. These communities have co-evolved with the human host and are important for human health. They can, however, also be a reservoir for pathogenic microorganisms.
Microbial Natural Products
Even today efficient drugs against many diseases are missing but finding new active substances is very complex. Support comes out of the ground. Myxobacteria are soil-living microorganisms that produce many active agents. Here you learn more about the search for new compounds with biological activity. This department is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) .
Microbial Proteomics
A genome contains all the information that is needed to build an organism like, for instance, a bacterium. One of functional genomics’ central questions is: How are these blueprints implemented so that relatively simple molecular codes ultimately give rise to a microorganism with the potential of getting us sick? What are some of the underlying mechanisms and under what conditions do they become activated?